Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Document:USA FDA Guidance for Industry - Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency Mar-2020: Difference between revisions

From GxPlex

Jump to: navigation, search
← Older edit
gxplex>GxPlexBot
Import from GxPlex Excel
Remove static References table, superseded by live #ask in Template:DocumentData (GxPlexBot)
 
(2 intermediate revisions by 2 users not shown)
Line 1: Line 1:
<noinclude>{{#set:
{{DocumentData
|DocReference=USA  FDA Guidance for Industry -
Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency  Mar-2020
|DocValidityArea=USA
|DocScopes=G
|DocName=FDA Guidance for Industry -
Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency
|DocVersion=Mar-2020
|DocStatus=Superseded / Invalid
|DocType=Official recommendation
|DocLanguage=EN
|DocDescription=Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency
Guidance for Industry, Investigators, and Institutional Review Boards
|DocRestricted=No
|DocSubmittedBy=Florian Adragna
|DocContributors=
}}</noinclude>
 
{{DocumentBox
|reference=USA  FDA Guidance for Industry -
|reference=USA  FDA Guidance for Industry -
Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency  Mar-2020
Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency  Mar-2020
Line 35: Line 17:
|contributors=
|contributors=
}}
}}
<noinclude>
== References ==
{| class="wikitable"
! Reference !! Scope !! Document part !! Language !! Preview
|-
| [[Reference:USA FDA Guidance for Industry - Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency Mar-2020 Q15]] || G || Q15 || EN || Q15. I am a study monitor and am unable to conduct on-site monitoring visits due to the COVID-19 public health emergency. May I remotely perform the site monitoring visit? What recommendations does ...
|}
</noinclude>

Latest revision as of 14:15, 16 July 2026


Document information
Reference USA FDA Guidance for Industry -

Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency Mar-2020

Validity area USA
Scope(s) G
Document name FDA Guidance for Industry -

Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency

Version / Revision Mar-2020
Status Superseded / Invalid
Document type Official recommendation
Language(s) EN
Description Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency

Guidance for Industry, Investigators, and Institutional Review Boards

Official source Official link
Restricted access No
Submitted by Florian Adragna
Contributors

References

 ScopeDocument partLanguagePreview
USA FDA Guidance for Industry - Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency Mar-2020 Q15GQ15ENQ15. I am a study monitor and am unable to conduct on-site monitoring visits due to the COVID-19 public health emergency. May I remotely perform the s…
Retrieved from "https://gxplex.org/index.php?title=Document:USA_FDA_Guidance_for_Industry_-_Conduct_of_Clinical_Trials_of_Medical_Products_During_the_COVID-19_Public_Health_Emergency_Mar-2020&oldid=20406"